A contemporary review of snoRNAs in cardiovascular health: RNA modification and beyond

Noah Peter Jagielski; Amit Kumar Rai; K. Shanmugha Rajan; Vatsal Mangal; Venkata Naga Srikanth Garikipati

doi:10.1016/j.omtn.2023.102087

A contemporary review of snoRNAs in cardiovascular health: RNA modification and beyond

Noah Peter Jagielski, Amit Kumar Rai, K. Shanmugha Rajan, Vatsal Mangal, Venkata Naga Srikanth Garikipati^*

^*Corresponding author for this work

Department of Chemical and Structural Biology

Research output: Contribution to journal › Review article › peer-review

1 Citation (Scopus)

Abstract

As cardiovascular diseases continue to be the leading cause of death worldwide, groundbreaking research is being conducted to mitigate their effects. This review looks into the potential of small nucleolar RNAs (snoRNAs) and the opportunity to use these molecular agents as therapeutic biomarkers for cardiovascular issues specific to the heart. Through an investigation of snoRNA biogenesis, functionality, and roles in cardiovascular diseases, this review relates our past and present knowledge of snoRNAs to the current scientific literature. Considering the initial discovery of snoRNAs and the studies thereafter analyzing the roles of snoRNAs in disease, we look forward to uncovering many other noncanonical functions that could lead researchers closer to finding preventive and curative solutions for cardiovascular diseases.

Original language	English
Article number	102087
Number of pages	10
Journal	Molecular Therapy Nucleic Acids
Volume	35
Issue number	1
Early online date	5 Dec 2023
DOIs	https://doi.org/10.1016/j.omtn.2023.102087
Publication status	Published - 12 Mar 2024

Bibliographical note

This work was partially supported by American Heart Association Innovative project Award 23IPA105444 , NIH grant HL164794 , and startup funds from the Temple University Medical Center to V.N.S.G. A.K.R. is supported by the American Heart Association-Post Doctoral Fellowship grant 2021AHA000POST000217114 . All of the figures were created and published using BioRender.com .

Funding

This work was partially supported by American Heart Association Innovative project Award 23IPA105444 , NIH grant HL164794 , and startup funds from the Temple University Medical Center to V.N.S.G. A.K.R. is supported by the American Heart Association-Post Doctoral Fellowship grant 2021AHA000POST000217114 . All of the figures were created and published using BioRender.com .

All Science Journal Classification (ASJC) codes

Molecular Medicine
Drug Discovery

Access to Document

10.1016/j.omtn.2023.102087Licence: CC BY-NC-ND

Cite this

@article{321f73a5d48f4ba89f2c38666d06e727,

title = "A contemporary review of snoRNAs in cardiovascular health: RNA modification and beyond",

abstract = "As cardiovascular diseases continue to be the leading cause of death worldwide, groundbreaking research is being conducted to mitigate their effects. This review looks into the potential of small nucleolar RNAs (snoRNAs) and the opportunity to use these molecular agents as therapeutic biomarkers for cardiovascular issues specific to the heart. Through an investigation of snoRNA biogenesis, functionality, and roles in cardiovascular diseases, this review relates our past and present knowledge of snoRNAs to the current scientific literature. Considering the initial discovery of snoRNAs and the studies thereafter analyzing the roles of snoRNAs in disease, we look forward to uncovering many other noncanonical functions that could lead researchers closer to finding preventive and curative solutions for cardiovascular diseases.",

author = "Jagielski, {Noah Peter} and Rai, {Amit Kumar} and Rajan, {K. Shanmugha} and Vatsal Mangal and Garikipati, {Venkata Naga Srikanth}",

note = "This work was partially supported by American Heart Association Innovative project Award 23IPA105444 , NIH grant HL164794 , and startup funds from the Temple University Medical Center to V.N.S.G. A.K.R. is supported by the American Heart Association-Post Doctoral Fellowship grant 2021AHA000POST000217114 . All of the figures were created and published using BioRender.com .",

year = "2024",

month = mar,

day = "12",

doi = "10.1016/j.omtn.2023.102087",

language = "English",

volume = "35",

journal = "Molecular Therapy Nucleic Acids",

issn = "2162-2531",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - A contemporary review of snoRNAs in cardiovascular health

T2 - RNA modification and beyond

AU - Jagielski, Noah Peter

AU - Rai, Amit Kumar

AU - Rajan, K. Shanmugha

AU - Mangal, Vatsal

AU - Garikipati, Venkata Naga Srikanth

N1 - This work was partially supported by American Heart Association Innovative project Award 23IPA105444 , NIH grant HL164794 , and startup funds from the Temple University Medical Center to V.N.S.G. A.K.R. is supported by the American Heart Association-Post Doctoral Fellowship grant 2021AHA000POST000217114 . All of the figures were created and published using BioRender.com .

PY - 2024/3/12

Y1 - 2024/3/12

N2 - As cardiovascular diseases continue to be the leading cause of death worldwide, groundbreaking research is being conducted to mitigate their effects. This review looks into the potential of small nucleolar RNAs (snoRNAs) and the opportunity to use these molecular agents as therapeutic biomarkers for cardiovascular issues specific to the heart. Through an investigation of snoRNA biogenesis, functionality, and roles in cardiovascular diseases, this review relates our past and present knowledge of snoRNAs to the current scientific literature. Considering the initial discovery of snoRNAs and the studies thereafter analyzing the roles of snoRNAs in disease, we look forward to uncovering many other noncanonical functions that could lead researchers closer to finding preventive and curative solutions for cardiovascular diseases.

AB - As cardiovascular diseases continue to be the leading cause of death worldwide, groundbreaking research is being conducted to mitigate their effects. This review looks into the potential of small nucleolar RNAs (snoRNAs) and the opportunity to use these molecular agents as therapeutic biomarkers for cardiovascular issues specific to the heart. Through an investigation of snoRNA biogenesis, functionality, and roles in cardiovascular diseases, this review relates our past and present knowledge of snoRNAs to the current scientific literature. Considering the initial discovery of snoRNAs and the studies thereafter analyzing the roles of snoRNAs in disease, we look forward to uncovering many other noncanonical functions that could lead researchers closer to finding preventive and curative solutions for cardiovascular diseases.

UR - http://www.scopus.com/inward/record.url?scp=85180081461&partnerID=8YFLogxK

U2 - 10.1016/j.omtn.2023.102087

DO - 10.1016/j.omtn.2023.102087

M3 - Review article

AN - SCOPUS:85180081461

SN - 2162-2531

VL - 35

JO - Molecular Therapy Nucleic Acids

JF - Molecular Therapy Nucleic Acids

IS - 1

M1 - 102087

ER -

A contemporary review of snoRNAs in cardiovascular health: RNA modification and beyond

Abstract

Bibliographical note

Funding

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this